Wilmington Pharmaceuticals develops and out-licenses patient-friendly, fast-dissolving formulations for established medicines with an unmet patient need for simpler, more reliable dosage forms. Applying commercially proven fast-dissolve delivery technologies to established medicines allows for rapid product development and commercialization.